azoxymethane has been researched along with zerumbone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kohno, H; Koshimizu, K; Mori, H; Murakami, A; Ohigashi, H; Safitri, R; Shimizu, M; Takahashi, D; Tanaka, T; Tsukio, Y; Yamamoto, K; Yoshitani, S | 1 |
| Hong, JE; Hwang, S; Jo, M; Lee, CG; Park, CO; Rhee, KJ | 1 |
2 other study(ies) available for azoxymethane and zerumbone
| Article | Year |
|---|---|
Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Cell Division; Colon; Colonic Neoplasms; Cyclooxygenase 2; Diet; Dinoprostone; Dose-Response Relationship, Drug; Glutathione Transferase; Intestinal Mucosa; Isoenzymes; Liver; Male; NAD(P)H Dehydrogenase (Quinone); Nucleolus Organizer Region; Precancerous Conditions; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Sesquiterpenes; Silver Staining; Zingiberaceae | 2001 |
Protective Effects of Zerumbone on Colonic Tumorigenesis in Enterotoxigenic
Topics: Administration, Oral; Animals; Azoxymethane; Bacteroides fragilis; Body Weight; Carcinogenesis; Colitis; Colonic Neoplasms; Dextran Sulfate; Female; Mice; Mice, Inbred BALB C; Protective Agents; Sesquiterpenes; Severity of Illness Index | 2020 |